Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 9.20
Change Today 0.00 / 0.00%
Volume 0.0
EMTC On Other Exchanges
Symbol
Exchange
OTC US
Tel Aviv
As of 10:24 AM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

elbit medical technologies l (EMTC) Snapshot

Open
$9.30
Previous Close
$9.30
Day High
$9.30
Day Low
$9.20
52 Week High
08/28/14 - $17.00
52 Week Low
08/25/15 - $9.10
Market Cap
76.9M
Average Volume 10 Days
219.5K
EPS TTM
$-0.01
Shares Outstanding
835.5M
EX-Date
12/11/06
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ELBIT MEDICAL TECHNOLOGIES L (EMTC)

Related News

No related news articles were found.

elbit medical technologies l (EMTC) Related Businessweek News

No Related Businessweek News Found

elbit medical technologies l (EMTC) Details

Elbit Medical Technologies Ltd., through its subsidiary, InSightec Ltd., develops, produces, and markets magnetic resonance imaging guided ultrasound equipment in Israel and internationally. It offers ExAblate, a system that is used to visualize the body anatomy, plan the treatment, and monitor treatment outcome in real time; and MR thermometry, a system that allows the physicians to control and adjust the treatment in real time. The company is headquartered in Tel Aviv, Israel.

elbit medical technologies l (EMTC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

elbit medical technologies l (EMTC) Key Developments

Elbit Medical Technologies Ltd. expected to report Q2 2015 results on August 27, 2015. This event was calculated by Capital IQ (Created on June 16, 2015).

Elbit Medical Technologies Ltd. expected to report Q2 2015 results on August 27, 2015. This event was calculated by Capital IQ (Created on June 16, 2015).

Elbit Medical Technologies Ltd., Special/Extraordinary Shareholders Meeting, Nov 03, 2014

Elbit Medical Technologies Ltd., Special/Extraordinary Shareholders Meeting, Nov 03, 2014., at 12:00 Israel Standard Time.

Elbit Medical Technologies Ltd. Obtains $12.5 Million Investment from a Chinese Investment Group

Elbit Medical Technologies Ltd. reported that it had obtained a $12.5 million investment from a Chinese investment group. The Chinese group includes Shanghai GEOC, Hengtong Investment Limited Partnership, and Fortune China. The financing round, announced by Elbit Medical several months ago, was at a company value of $200 million for InSightec, before money. Elbit Medical owns 37.6% of InSightec.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EMTC:IT 9.20 0.00

EMTC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EMTC.
View Industry Companies
 

Industry Analysis

EMTC

Industry Average

Valuation EMTC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELBIT MEDICAL TECHNOLOGIES L, please visit www.elbitimaging.com/126-en/Elbit-Imaging.aspx. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.